Nurix Therapeutics Inc (NRIX)
Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025)
Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025)
Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer
ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform
Other Scheme Of Arrangement :: Minutes Of Scheme Meeting Held On 8 May 2025
Other Scheme Of Arrangement :: Despatch Of Election Forms And Accompanying Document And Confirmation Of Election Period
Holding(s) in Company
How To Print From Your Phone: A Complete Step-by-Step Guide
Best Basement Dehumidifiers for Preventing Mold and Dampness
What To Do When Your iPhone Is Stuck on an iOS Update
The Most Popular Gaming PC Specs Right Now (On Steam)